Urohealth Systems will take over Imagyn Medical in a stock deal which values Imagyn at about $70 million. The deal will add micro-invasive systems to diagnose and treat gynaecological and reproductive disorders to Urohealth's products in urology and general surgery.
Urohealth to acquire gynaecology specialist Imagyn
Urohealth Systems will take over Imagyn Medical in a stock deal which values Imagyn at about $70 million. The deal will add micro-invasive systems to diagnose and treat gynaecological and reproductive disorders to Urohealth's products in urology and general surgery.